Tyrosine kinase inhibitors
US6162804A · kind A · utility
96Cited by
20References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 11, 1999 |
| Grant date | Dec 19, 2000 |
| Priority date | — |
| Expiry date | Mar 11, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to benzinidazole compounds which inhibit tyrosine kinase enzymes, compositions which contain tyrosine kinase inhibiting compounds and methods of using tyrosine kinase inhibitors to treat tyrosine kinase-dependent diseases/conditions such as angiogenenesis, cancer, atherosclerosis, diabetic retinopathy or autoimmune diseases, in mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.